Zarubaev V V, Beliaevskaia S V, Sirotkin A K, Anfimov P M, Nebol'sin V E, Kiselev O I, Reĭkhart D V
Vopr Virusol. 2011 Sep-Oct;56(5):21-5.
The aim of this investigation was to study the effect of ingavirin on the structure and properties of influenza virions forming in its presence. The infectious activity of the virus and the morphology of the virions were analyzed by titration in cell culture and electron microscopy, respectively. The use of ingavirin was shown to reduce the proportion of morphologically intact virions and to increase that of filamentous and giant particles. No defects of surface glycoproteins were observed. The effect of the drug did not depend on the chosen model of virus replication and it was similarly shown in both cultured human cells and laboratory animals. In MDCK and A549 cells and in the mouse lungs, viral infectious activity was decreased by 1-2 orders of magnitude in relation to a model. The findings suggest that Ingavirin is able to impair the processes of viral morphogenesis, which in turn leads to a reduction in the infectivity of progeny virions.
本研究的目的是研究因加维林对在其存在下形成的流感病毒粒子的结构和特性的影响。分别通过细胞培养滴定和电子显微镜分析病毒的感染活性和病毒粒子的形态。结果表明,使用因加维林可降低形态完整的病毒粒子比例,并增加丝状和巨型颗粒的比例。未观察到表面糖蛋白缺陷。该药物的作用不取决于所选的病毒复制模型,在培养的人类细胞和实验动物中均有类似表现。在MDCK和A549细胞以及小鼠肺中,与模型相比,病毒感染活性降低了1-2个数量级。这些发现表明,因加维林能够损害病毒形态发生过程,进而导致子代病毒粒子的感染性降低。